Showing results (91-100 of 2,361) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|October 10, 2023
Evaluation of synthetic aminoquinoline derivatives as urease inhibitors: in vitro, in silico and kinetic studiesFaiza Seraj, Khalid Mohammed Khan, Jamshed Iqbal, et al.
Future Medicinal Chemistry|October 25, 2023
Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapyAkshatha Handattu Shankaranarayana, Bhagyalalitha Meduri, Gurubasavaraj Veeranna Pujar, et al.
Future Medicinal Chemistry|October 25, 2023
Keto-bridged dual triazole-linked benzenesulfonamides as potent carbonic anhydrase and cathepsin B inhibitorsLalit Vats, Priyanka Arya, Rajiv Kumar, et al.
Future Medicinal Chemistry|October 25, 2023
New horizons in lung cancer management through ATR/CHK1 pathway modulationRiya Thapa, Obaid Afzal, Asif Ahmad Bhat, et al.
Future Medicinal Chemistry|October 25, 2023
Pharmacokinetic correlation of structurally modified chalcone derivatives as promising leads to treat tuberculosisSarvesh Sabarathinam, Nila Ganamurali, Sanjana Satheesh, et al.
Future Medicinal Chemistry|September 29, 2023
Inherent efficacies of pyrazole-based derivatives for cancer therapy: the interface between experiment and in silicoZanele F Dube, Opeyemi S Soremekun, Thandokuhle Ntombela, et al.
Future Medicinal Chemistry|September 21, 2023
Synthesis and HDAC1 inhibitory activity of a novel series of coumarin-based amide derivatives for treatment of cancerSharba Tasneem, M Mumtaz Alam, Suhel Parvez, et al.
Future Medicinal Chemistry|July 19, 2023
Using novel click chemistry algorithm to design D3R inhibitors as blood-brain barrier permeantsAlexander A Kovalenko, Yuri B Porozov, Ekaterina V Skorb, et al.
Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.
Future Medicinal Chemistry|July 12, 2023
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitorsVinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, et al.
Pageof 237